Merck Global Health Innovation Fund, LLC
CIK 1547132 · last filed 2018-06-22
Merck Global Health Innovation Fund, LLC is a corporate insider who has filed 3 SEC Form 4 insider transactions across 2 companies since 2016. The most recent filing shows the insider bought $2.5M of ECOR on Jun 22, 2018. Across all open-market trades the lifetime net is +$2.5M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $1.4M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.36M
2
3
$2.50M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ECOR | 10%+ Owner | 223,292 | $6.09 | $1.36M | $2.50M | 1 | 2018-06-22 |
| OPGEN INC (OPGN.W) Delisted | 10%+ Owner | 5,413,449 | — | — | $0 | 2 | 2016-06-29 |
Recent Filings
3 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-06-22 | ECOR | Buy (P) | +166,666 | $2.50M | EDGAR |
| 2016-06-29 | OPGEN INC (OPGN.W) Delisted | Mixed | +8,203,281 | $0 | EDGAR |
| 2016-05-24 | OPGEN INC (OPGN.W) Delisted | Mixed | +3,600,000 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.